UAB Magazine Weekly Archive
Innovative UAB Course Gives Students Roles of a Lifetime
By Tyler Greer
 |
Andrew Keitt (right) encourages students to play active roles in history's great debates.
|
What thoughts raced through Galileo’s mind when he first trained his telescope skyward and saw the craters of the moon? How did he, a devout Catholic, feel when his insistence that the Earth revolves around the Sun brought him into direct conflict with the Church? And just what was it about that hypothesis that troubled church leaders so deeply?
UAB historian Andrew Keitt, Ph.D., knows the answers to these questions. And it would be easy for him to stand up in front of his classroom and share them in a standard lecture. But for the past several semesters, Keitt has been experimenting with a different way of teaching—a form of time travel called Reacting to the Past, in which students live ideas, rather than memorize them.
|
|
Read more...
|
UAB Sculptor Builds a Masterpiece
By Charles Buchanan
John Powers creates art that won’t sit still. It rises and falls, sways, types, clicks, clacks, and rolls like waves. An assistant professor of sculpture in UAB’s Department of Art and Art History, Powers designs intricate kinetic pieces inspired by natural history, architecture, technology, and the passage of time. It can take up to a year to plan and build one sculpture, each one a blend of carpentry, mechanics, symbolism, and sound.
In this video, Powers invites you into his studio as he constructs “Remember,” a large-scale piece that gives new life—and new meaning—to old typewriters.
More Information
|
UAB Uses Nutrition Science to Fight AIDS in Africa
By Tara Hulen
As medical mysteries go, this one is particularly heartbreaking. Several years ago, UAB clinicians began a large-scale program to bring lifesaving antiretroviral therapy to Zambia. But to their surprise, the same wonder drugs that revolutionized AIDS treatment in the United States produced untoward side effects in Africa.
Scientists at UAB’s Centre for Infectious Disease Research in Zambia (CIDRZ), which administers the program, were perplexed. “In the first 90 days, an unexpectedly large number of patients die after the drugs are started,” says Douglas Heimburger, M.D., a researcher and professor in nutrition sciences and medicine at UAB. “But if they can get through the first 90 days, the patients’ mortality rates are very similar to patients on similar therapies in the United States.”
|
|
Read more...
|
|
|
|
|
Page 8 of 12 |
|
